Agios Pharmaceuticals, Inc. (AGIO) is a publicly traded Healthcare sector company. As of September 15, 2026, AGIO trades at $32.36 with a market cap of $2.01B and a P/E ratio of -4.77. AGIO moved -2.00% today. Year to date, AGIO is +22.04%; over the trailing twelve months it is -9.68%. Its 52-week range spans $22.24 to $46.00. Analyst consensus is strong buy with an average price target of $43.40. Rallies surfaces AGIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest AGIO news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $32.36 |
| Market Cap | $2.01B |
| P/E Ratio | -4.77 |
| EPS | $-7.01 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.00 |
| 52-Week Low | $22.24 |
| Volume | 93.51K |
| Avg Volume | 0 |
| Revenue (TTM) | $98.34M |
| Net Income | $-411.29M |
| Gross Margin | 91.99% |
8 analysts cover AGIO: 0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $43.40.